Alamar Biosciences, Inc.

NasdaqGS:ALMR Stock Report

Market Cap: US$1.5b

Alamar Biosciences Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqGS:ALMR Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
20 Apr 26BuyUS$3,999,998IIF Management Company LLCCompany235,294US$17.00
16 Apr 26BuyUS$5,100,000Sands Capital Life Sciences Pulse Fund II, L.P.Company300,000US$17.00

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of ALMR?
Owner TypeNumber of SharesOwnership Percentage
Institutions4,847,1586.99%
Individual Insiders7,243,35010.5%
VC/PE Firms21,753,82231.4%
General Public35,466,85651.2%

Dilution of Shares: ALMR only recently listed within the past 12 months

Top Shareholders

Top 17 shareholders own 48.83% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
15.3%
Qiming Weichuang Venture Capital Management (Shanghai) Company Limited
10,594,547US$232.7m0%10.44%
9.18%
IIF Management Company LLC
6,363,612US$139.7m0%no data
6.92%
Zhuhai Sherpa Equity Investment Management Company Limited
4,795,663US$105.3m0%47.05%
5.67%
Sands Capital Management, LLC
3,930,926US$86.3m0%0.23%
4.46%
Yuling Luo
3,088,217US$67.8m0%no data
4.3%
Lian Luo
2,977,665US$65.4m0%no data
1.04%
Shiping Chen
722,885US$15.9m0%no data
0.82%
ARK Investment Management LLC
568,303US$12.5m0%0.07%
0.66%
Timothy White
454,583US$10.0m0%no data
0.31%
AllianceBernstein L.P.
213,152US$4.7m0%no data
0.12%
Vanguard Capital Management, LLC
83,698US$1.8m0%no data
0.023%
Columbia Management Investment Advisers, LLC
15,640US$343.4k0%no data
0.019%
Vanguard Fiduciary Trust Company
12,867US$282.5k0%no data
0.016%
Vanguard Portfolio Management, LLC
11,344US$249.2k0%no data
0.013%
Hartford Funds Management Company, LLC
9,100US$199.8k0%no data
0.0019%
Wellington Management Group LLP
1,300US$28.6k0%no data
0.0012%
Vanguard Global Advisers, LLC
828US$18.1k0%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/06/20 00:38
End of Day Share Price 2026/06/18 00:00
Earnings2026/03/31
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Alamar Biosciences, Inc. is covered by 5 analysts. 5 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Michael RyskinBofA Global Research
Casey WoodringJ.P. Morgan
Puneet SoudaLeerink Partners LLC